 Kejun Guo
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antiviral Agents | 4 | 2022 | 744 | 1.050 |
Why?
| | Interferons | 3 | 2024 | 202 | 0.910 |
Why?
| | HIV-1 | 7 | 2022 | 864 | 0.870 |
Why?
| | Gastrointestinal Tract | 3 | 2022 | 195 | 0.840 |
Why?
| | Friend murine leukemia virus | 7 | 2021 | 30 | 0.830 |
Why?
| | Cytidine Deaminase | 8 | 2018 | 61 | 0.830 |
Why?
| | Retroviridae Infections | 7 | 2021 | 47 | 0.810 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 3 | 2022 | 19 | 0.770 |
Why?
| | Interferon-alpha | 2 | 2020 | 198 | 0.730 |
Why?
| | Dendritic Cells | 3 | 2020 | 483 | 0.730 |
Why?
| | Interferon-beta | 1 | 2020 | 92 | 0.660 |
Why?
| | HIV Infections | 9 | 2022 | 2836 | 0.660 |
Why?
| | Antibodies, Neutralizing | 5 | 2022 | 286 | 0.480 |
Why?
| | Immunoglobulin Variable Region | 1 | 2015 | 80 | 0.470 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 83 | 0.460 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 86 | 0.440 |
Why?
| | B-Lymphocytes | 2 | 2015 | 847 | 0.340 |
Why?
| | Dysbiosis | 4 | 2022 | 181 | 0.310 |
Why?
| | Virus Replication | 6 | 2017 | 483 | 0.300 |
Why?
| | Adaptive Immunity | 2 | 2021 | 165 | 0.260 |
Why?
| | Interferon Type I | 2 | 2018 | 140 | 0.260 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2022 | 1091 | 0.260 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2024 | 34 | 0.260 |
Why?
| | Antibodies, Viral | 4 | 2022 | 625 | 0.250 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2022 | 109 | 0.220 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 121 | 0.210 |
Why?
| | Exons | 1 | 2024 | 355 | 0.210 |
Why?
| | Intestinal Mucosa | 3 | 2018 | 623 | 0.210 |
Why?
| | Alternative Splicing | 1 | 2024 | 229 | 0.200 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2021 | 12 | 0.190 |
Why?
| | Blood | 1 | 2022 | 107 | 0.180 |
Why?
| | Membrane Glycoproteins | 2 | 2016 | 500 | 0.180 |
Why?
| | Antigens, CD | 2 | 2016 | 521 | 0.180 |
Why?
| | Immunoglobulin A | 1 | 2022 | 211 | 0.170 |
Why?
| | Specimen Handling | 1 | 2022 | 183 | 0.170 |
Why?
| | Proteins | 2 | 2018 | 1009 | 0.170 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1774 | 0.160 |
Why?
| | Colon | 2 | 2022 | 282 | 0.160 |
Why?
| | Keratinocytes | 2 | 2018 | 249 | 0.150 |
Why?
| | Immunoglobulin M | 2 | 2022 | 289 | 0.150 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 11 | 0.150 |
Why?
| | Cullin Proteins | 1 | 2018 | 12 | 0.140 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 886 | 0.140 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 812 | 0.140 |
Why?
| | Human papillomavirus 16 | 1 | 2018 | 35 | 0.140 |
Why?
| | Transcriptome | 2 | 2022 | 971 | 0.140 |
Why?
| | Signal Transduction | 2 | 2024 | 5079 | 0.140 |
Why?
| | Viral Tropism | 1 | 2017 | 31 | 0.140 |
Why?
| | Proteome | 1 | 2022 | 472 | 0.140 |
Why?
| | Proteolysis | 1 | 2018 | 177 | 0.130 |
Why?
| | Enterobacteriaceae | 1 | 2017 | 40 | 0.130 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2017 | 137 | 0.130 |
Why?
| | Bacterial Translocation | 1 | 2017 | 43 | 0.130 |
Why?
| | Butyrates | 1 | 2017 | 61 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2022 | 3556 | 0.130 |
Why?
| | Immunologic Factors | 1 | 2018 | 236 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 2 | 2022 | 697 | 0.130 |
Why?
| | Lymphocyte Activation | 2 | 2017 | 1142 | 0.120 |
Why?
| | Antibody Diversity | 1 | 2015 | 16 | 0.120 |
Why?
| | Immunoglobulin G | 2 | 2022 | 893 | 0.120 |
Why?
| | Virion | 2 | 2015 | 93 | 0.120 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 97 | 0.110 |
Why?
| | Leukemia, Experimental | 1 | 2014 | 27 | 0.110 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2015 | 88 | 0.110 |
Why?
| | Macaca mulatta | 1 | 2015 | 166 | 0.110 |
Why?
| | Tumor Virus Infections | 1 | 2014 | 49 | 0.110 |
Why?
| | Bacteria | 2 | 2022 | 858 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 385 | 0.110 |
Why?
| | Base Sequence | 2 | 2015 | 2181 | 0.110 |
Why?
| | Papillomavirus Infections | 1 | 2018 | 325 | 0.110 |
Why?
| | Papillomaviridae | 1 | 2014 | 125 | 0.110 |
Why?
| | Gene Frequency | 1 | 2015 | 521 | 0.110 |
Why?
| | Intestines | 1 | 2017 | 357 | 0.110 |
Why?
| | Viral Load | 4 | 2021 | 466 | 0.100 |
Why?
| | Immunity, Innate | 2 | 2024 | 828 | 0.100 |
Why?
| | Endoribonucleases | 1 | 2013 | 81 | 0.100 |
Why?
| | Animals | 12 | 2024 | 36940 | 0.100 |
Why?
| | Mice, Knockout | 5 | 2021 | 3015 | 0.090 |
Why?
| | Humans | 16 | 2024 | 137585 | 0.090 |
Why?
| | Endogenous Retroviruses | 1 | 2012 | 37 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 539 | 0.090 |
Why?
| | Antibody Formation | 1 | 2011 | 298 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 991 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1272 | 0.080 |
Why?
| | HEK293 Cells | 2 | 2024 | 730 | 0.080 |
Why?
| | Young Adult | 3 | 2020 | 13209 | 0.070 |
Why?
| | Reverse Transcription | 2 | 2021 | 20 | 0.070 |
Why?
| | Immunity, Humoral | 2 | 2022 | 116 | 0.070 |
Why?
| | Interleukin-2 | 2 | 2022 | 455 | 0.070 |
Why?
| | Adult | 5 | 2020 | 37929 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5757 | 0.060 |
Why?
| | Mice | 7 | 2021 | 17787 | 0.060 |
Why?
| | Middle Aged | 4 | 2020 | 33479 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 2189 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2017 | 4193 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2024 | 404 | 0.050 |
Why?
| | Female | 6 | 2021 | 73304 | 0.050 |
Why?
| | Male | 5 | 2021 | 67762 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 50 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2022 | 121 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5472 | 0.050 |
Why?
| | World Health Organization | 1 | 2022 | 123 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 218 | 0.040 |
Why?
| | RNA, Viral | 2 | 2016 | 656 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 364 | 0.040 |
Why?
| | Enzyme Stability | 1 | 2018 | 70 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 2013 | 4295 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 145 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.030 |
Why?
| | Palatine Tonsil | 1 | 2017 | 48 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 112 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 88 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2016 | 58 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2016 | 144 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2016 | 98 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 558 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 337 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2017 | 499 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 900 | 0.030 |
Why?
| | Phenotype | 2 | 2016 | 3196 | 0.030 |
Why?
| | APOBEC-1 Deaminase | 1 | 2014 | 5 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 316 | 0.030 |
Why?
| | Cervix Uteri | 1 | 2014 | 48 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 491 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1129 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 549 | 0.030 |
Why?
| | Germinal Center | 1 | 2014 | 58 | 0.030 |
Why?
| | Viremia | 1 | 2014 | 138 | 0.030 |
Why?
| | Feces | 1 | 2017 | 484 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1178 | 0.030 |
Why?
| | Acute Disease | 1 | 2016 | 1007 | 0.020 |
Why?
| | Phylogeny | 1 | 2017 | 904 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 2016 | 449 | 0.020 |
Why?
| | Inbreeding | 1 | 2012 | 18 | 0.020 |
Why?
| | Spleen | 1 | 2014 | 514 | 0.020 |
Why?
| | NF-kappa B | 1 | 2016 | 691 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2012 | 409 | 0.020 |
Why?
| | Plasma | 1 | 2011 | 212 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2900 | 0.020 |
Why?
| | Microbiota | 1 | 2017 | 762 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2011 | 452 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1250 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2607 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3958 | 0.010 |
Why?
| | Aged | 1 | 2017 | 23961 | 0.010 |
Why?
| | Child | 1 | 2017 | 21935 | 0.010 |
Why?
|
|
Guo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|